Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients: A Nationwide Cohort Study

To analyze the association between use of DPP-4 inhibitors and acute pancreatitis in high-risk type 2 diabetic patients. A retrospective nationwide cohort study was conducted using the Taiwan National Health Insurance claim database. The risk associated with sitagliptin was compared to that with aca...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chia-Hsuin, Lin, Jou-Wei, Chen, Shu-Ting, Lai, Mei-Shu, Chuang, Lee-Ming, Chang, Yi-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998601/
https://www.ncbi.nlm.nih.gov/pubmed/26886601
http://dx.doi.org/10.1097/MD.0000000000002603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998601/
https://www.ncbi.nlm.nih.gov/pubmed/26886601
http://dx.doi.org/10.1097/MD.0000000000002603

Ejemplares similares